Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Pfizer sent out questionnaires Wednesday to roster and non-roster agencies concerning three of its drug brands previously handled by Deutsch, the client confirmed.
Sources said the RFPs are due back March 21 for its Zyrtec (allergy), Zoloft (anti-depressant) and Bextra (pain reliever) brands. The New York client’s questionnaires list projected “marketing communications spending” for each brand as being “in the range of $50 to $75 million,” sources said. The review is for direct-to-consumer advertising.
Pfizer
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in